Overview Single Ascending Dose Study of TRN-157 in Healthy Subjects Status: Completed Trial end date: 2014-09-01 Target enrollment: Participant gender: Summary This single ascending dose study is to determine and evaluate the safety and tolerability of TRN-157 in approximately 40 healthy subjects. Phase: Phase 1 Details Lead Sponsor: Theron Pharmaceuticals, Inc.